National and Kapodistrian University of Athens
Καταγραφή νέων γονιδιακών μεταλλάξεων και γενετικών πολυμορφισμών σε νεογνά και παιδιά με θρόμβωση σε ποικίλες θέσεις
Abstract
dc:descriptionThe aim of the study was to compare the distributions of mutations/polymorphisms in genes affecting hemostasis (FV Leiden-FVL, FV H1298R-FVR2, FII 20210A, b-Fib 455G>A, FXIII V34L, PAI-1 4G, ΗΡΑ-1b) or homocysteine metabolism (MTHFR C677T, MTHFR A1298C) and combinations of them, among children with thrombosis and controls, and also to associate the carriage of these mutations/polymorphisms with their corresponding proteins in children with a thrombotic event. Polymerase Chain Reaction (PCR) technique, coagulation tests and High Performance Liquid Chromatography (HPLC) were used for the detection of gene mutations/polymorphisms, hemostasis proteins and homocysteine levels, respectively, in 141 children with thrombosis at various sites (mean age: 5.3 years). Thirty one cases (22%) had congenital CNS thrombosis. At diagnosis, 26% of cases were neonates. Thrombosis was more frequent in boys (p=0.021). No studied mutation/polymorphism was found to be a risk factor for thrombosis, except for FVLeiden (odds ratio 3.8, 95% CΙ 1.4-10.6), the presence of which was twice as high in children with congenital thrombosis (odds ratio 6.82, 95% CΙ 2.0-22.8). The risk of thrombosis for FVLeiden carriers was also twice as high in children with idiopathic thrombosis (odds ratio 5.7) than in thrombosed children with secondary thrombosis (odds ratio 2.7). FVLeiden carriers had an odds ratio of 5.9 (95% CI 1.8-19.6) in the absence of FVR2. The joint distributions of MTHFR C677T and MTHFR A1298T and FXIII Val34Leu with PAI-1 4G were the same among children and controls. In thrombosed children, activated protein C resistance ratio was significantly lower in the presence of FVLeiden (p<0.001). Fibrinogen levels, although higher in the presence of b-Fib 455g>A, did not reach statistical significance, neither prothrombin levels were higher in FII20210A carriers, except in the subgroup of patients with CNS thrombosis. Double heterozygotes in both MTHFR C677T and MTHFR A1298T or homozygotes in either of them had significantly elevated homocysteine levels than in heterozygotes for one or the carriers of the wild type. Hyperhomocysteinaemia was only detected in three cases.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Komitopoulou, Anna
- Κομιτοπούλου, Άννα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21004